Skip to main content
. Author manuscript; available in PMC: 2011 Jul 1.
Published in final edited form as: Cancer Res. 2010 Jun 8;70(13):5486–5496. doi: 10.1158/0008-5472.CAN-10-0713

Fig 1.

Fig 1

Type II endometrial cancer had elevated Nrf2 expression. (A) The left panels represent H&E staining and the right panels represent IHC staining with a monoclonal Nrf2 antibody. No Nrf2 expression was detected in benign tumors or in endometrial endometrioid carcinoma (EEC). However, Nrf2 staining was observed in endometrial serous carcinoma (ESC). (B) Two consecutive tissue sections were analyzed by IHC for Nrf2 (left panels) and HO-1 (right panels).